Table 1.
Compounds | Company | Mechanism | Clinical trial |
---|---|---|---|
AMG 510 | Amgen/Carmot Therapeutics | KRASG12C inhibitor | NCT03600883 |
MRTX849 | Mirati (ex Array) | KRASG12C inhibitor | NCT03785249 |
KRAS TCR | Gilead (ex Kite/NCI) | Anti-KRASG12D engineered T-cell receptor | NCT03745326 |
AZD4785 | AstraZeneca/Ionis | KRAS antisense oligonucleotide | NCT03101839 |